Historic Win for Electrophysiology Reimbursement in Ambulatory Surgery Centers Provides Unique Opportunity for Catheter Precision’s LockeT Device

FORT MILL, S.C., Nov. 25, 2025 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (VTAK - NYSE/American), a US based medical device company focused on developing technologically advanced products for the cardiac electrophysiology market today announced that the recent addition of key ablation procedures to ambulatory surgery centers (ASC) by Centers for Medicare and Medicaid services (CMS) provides a unique and new opportunity to expand the commercialization of LockeT.

Read more at globenewswire.com